Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm.
The brain aneurysm treatment market for is expected to grow, owing to factors such as increasing prevalence of brain aneurysm and associated risk factors and rise in research and development activities are likely to have a positive impact on the growth of the market in coming years.
How is a Brain Aneurysm Treated?
The treatment options for a brain aneurysm depend on a few things. These things include your age, size and location of the aneurysm, any additional risk factors, and your overall health.
If you have an aneurysm with a low risk of rupture, you and your doctor may want to continue to observe your condition rather than do surgery. You might make this choice because surgery also has risks. Your doctor may suggest ways to keep your blood vessels as healthy as possible, such as managing high blood pressure and not smoking. If your aneurysm is large or causing pain or other symptoms, though, or if you have had a previous ruptured aneurysm, your doctor may recommend surgery.
During this procedure, a small tube is inserted into the affected artery and positioned near the aneurysm. For coil embolization, soft metal coils are then moved through the tube into the aneurysm, filling the aneurysm and making it less likely to rupture. In mesh embolization, mesh is placed in the aneurysm, reducing blood flow to the aneurysm and making it less likely to rupture. These procedures are less invasive than surgery. But they involve risks, including rupture of the aneurysm.
Leading companies operating in the Brain Aneurysm Treatment Market are Stryker Corporation, MicroPort Scientific Corporation, Terumo Corporation, Mizuho Medical Co, Ltd, Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., KANEKA CORPORATION, adeor medical AG, and Evasc Medical Systems Corp among others.
Market Segmentation :
Based on Type, the Brain Aneurysm Treatment market is segmented into medication and surgery. In 2019 medication held the largest share of the market. However, surgery segment is expected to register the highest CAGR in the market during the forecast period.
Want To Know More about Genetic Engineering..??